- Home
- HRMY vs DJTWW Comparison
HRMY vs DJTWW Comparison
Compare HRMY & DJTWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- DJTWW
- Stock Information
- Founded
- HRMY 2017
- DJTWW 2021
- Country
- HRMY United States
- DJTWW United States
- Employees
- HRMY N/A
- DJTWW 29
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- DJTWW Computer Software: Programming Data Processing
- Sector
- HRMY Health Care
- DJTWW Technology
- Exchange
- HRMY Nasdaq
- DJTWW Nasdaq
- Market Cap
- HRMY 2.1B
- DJTWW 2.5B
- IPO Year
- HRMY 2020
- DJTWW N/A
- Fundamental
- Price
- HRMY $32.29
- DJTWW $8.97
- Analyst Decision
- HRMY Strong Buy
- DJTWW
- Analyst Count
- HRMY 9
- DJTWW 0
- Target Price
- HRMY $55.33
- DJTWW N/A
- AVG Volume (30 Days)
- HRMY 678.1K
- DJTWW 172.0K
- Earning Date
- HRMY 10-28-2025
- DJTWW 04-02-2025
- Dividend Yield
- HRMY N/A
- DJTWW N/A
- EPS Growth
- HRMY 58.41
- DJTWW N/A
- EPS
- HRMY 3.10
- DJTWW N/A
- Revenue
- HRMY $772,527,000.00
- DJTWW $3,369,800.00
- Revenue This Year
- HRMY $20.09
- DJTWW N/A
- Revenue Next Year
- HRMY $16.86
- DJTWW N/A
- P/E Ratio
- HRMY $10.42
- DJTWW N/A
- Revenue Growth
- HRMY 17.74
- DJTWW N/A
- 52 Week Low
- HRMY $26.47
- DJTWW $6.53
- 52 Week High
- HRMY $41.61
- DJTWW $44.83
- Technical
- Relative Strength Index (RSI)
- HRMY 30.41
- DJTWW N/A
- Support Level
- HRMY $31.61
- DJTWW N/A
- Resistance Level
- HRMY $37.05
- DJTWW N/A
- Average True Range (ATR)
- HRMY 1.18
- DJTWW 0.02
- MACD
- HRMY -0.59
- DJTWW -0.74
- Stochastic Oscillator
- HRMY 10.19
- DJTWW 0.51
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.